Nurix Therapeutics

Forecast & Rating14 analysts currently cover Nurix Therapeutics, with about 92.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $33.93, about 29.8% upside from the current price of $26.14. Price targets range from $25.00 to $45.00 — a wide spread, showing clear disagreement over just how much Nurix Therapeutics can rise. Historically, about 35.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Nurix Therapeutics closely still see room for the stock to rise. Data as of Sep 4, 2026; for reference only and not investment advice.